74 related articles for article (PubMed ID: 1737335)
21. Metabolic activation of pyrolysate arylamines by human liver microsomes; possible involvement of a P-488-H type cytochrome P-450.
Yamazoe Y; Abu-Zeid M; Yamauchi K; Kato R
Jpn J Cancer Res; 1988 Nov; 79(11):1159-67. PubMed ID: 3147272
[TBL] [Abstract][Full Text] [Related]
22. [Cytochrome P-450 in human fetal liver. Properties of P-450 HFLa,a form of cytochrome P-450 in human fetal livers].
Kitada M
Yakugaku Zasshi; 1991 Mar; 111(3):158-69. PubMed ID: 2066864
[TBL] [Abstract][Full Text] [Related]
23. Interspecies homology of cytochrome P-450: toxicological significance of cytochrome P-450 cross-reactive with anti-rat P-448-H antibodies in liver microsomes from dogs, monkeys and humans.
Ohta K; Kitada M; Ohi H; Komori M; Nagashima K; Sato N; Muroya K; Kodama T; Nagao M; Kamataki T
Mutat Res; 1989 Jul; 226(3):163-7. PubMed ID: 2501680
[TBL] [Abstract][Full Text] [Related]
24. Function and localization of cytochromes P450 involved in the metabolic activation of food-derived heterocyclic amines.
McKinnon RA; McManus ME
Princess Takamatsu Symp; 1995; 23():145-53. PubMed ID: 8844805
[TBL] [Abstract][Full Text] [Related]
25. Prostaglandin-H synthase mediated metabolism and mutagenic activation of 2-amino-3-methylimidazo [4,5-f] quinoline (IQ).
Wolz E; Wild D; Degen GH
Arch Toxicol; 1995; 69(3):171-9. PubMed ID: 7717873
[TBL] [Abstract][Full Text] [Related]
26. Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis.
Bourdi M; Larrey D; Nataf J; Bernuau J; Pessayre D; Iwasaki M; Guengerich FP; Beaune PH
J Clin Invest; 1990 Jun; 85(6):1967-73. PubMed ID: 2347920
[TBL] [Abstract][Full Text] [Related]
27. Activation of the food-derived mutagen 2-amino-3-methylimidazo[4, 5-f]quinoline by human-liver microsomes.
McManus ME; Burgess W; Stupans I; Trainor KJ; Fenech M; Robson RA; Morley AA; Snyderwine EG
Mutat Res; 1988 Feb; 204(2):185-93. PubMed ID: 3278209
[TBL] [Abstract][Full Text] [Related]
28. An anti-peptide antibody targeted to a specific region of rat cytochrome P-450IA2 inhibits enzyme activity.
Edwards RJ; Singleton AM; Murray BP; Sesardic D; Rich KJ; Davies DS; Boobis AR
Biochem J; 1990 Mar; 266(2):497-504. PubMed ID: 1690539
[TBL] [Abstract][Full Text] [Related]
29. Stable expression of human CYP1A2 and N-acetyltransferases in Chinese hamster CHL cells: mutagenic activation of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline.
Yanagawa Y; Sawada M; Deguchi T; Gonzalez FJ; Kamataki T
Cancer Res; 1994 Jul; 54(13):3422-7. PubMed ID: 8012961
[TBL] [Abstract][Full Text] [Related]
30. Purification and characterization of human liver microsomal cytochrome P-450 2A6.
Yun CH; Shimada T; Guengerich FP
Mol Pharmacol; 1991 Nov; 40(5):679-85. PubMed ID: 1944238
[TBL] [Abstract][Full Text] [Related]
31. Characterization of monkey cytochrome P450, P450 CMLd, responsible for S-mephenytoin 4-hydroxylation in hepatic microsomes of cynomolgus monkeys.
Ohmori S; Chiba K; Nakasa H; Horie T; Kitada M
Arch Biochem Biophys; 1994 Jun; 311(2):395-401. PubMed ID: 8203903
[TBL] [Abstract][Full Text] [Related]
32. Metabolic activation of food mutagens by liver and lung enzymes from rats, pigs and oxen.
Tjøtta K; Aune T
Mutat Res; 1991 Nov; 251(1):7-11. PubMed ID: 1944377
[TBL] [Abstract][Full Text] [Related]
33. Mutagenic activation of IQ and Me-IQ by liver and lung microsomes from rabbit and mouse, and with isolated lung cells from the rabbit.
Aune T; Aune KT
Carcinogenesis; 1986 Feb; 7(2):273-6. PubMed ID: 3948315
[TBL] [Abstract][Full Text] [Related]
34. Metabolic activation of mutagenic tryptophan pyrolysis products by rat liver microsomes.
Ishii K; Yamazoe Y; Kamataki T; Kato R
Cancer Res; 1980 Jul; 40(7):2596-600. PubMed ID: 6771001
[TBL] [Abstract][Full Text] [Related]
35. Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons.
Shimada T; Martin MV; Pruess-Schwartz D; Marnett LJ; Guengerich FP
Cancer Res; 1989 Nov; 49(22):6304-12. PubMed ID: 2509067
[TBL] [Abstract][Full Text] [Related]
36. Purification and characterization of a cytochrome P-450 isozyme catalyzing bunitrolol 4-hydroxylation in liver microsomes of male rats.
Suzuki T; Narimatsu S; Fujita S; Masubuchi Y; Umeda S; Imaoka S; Funae Y
Drug Metab Dispos; 1992; 20(3):367-73. PubMed ID: 1355709
[TBL] [Abstract][Full Text] [Related]
37. Prostaglandin H synthase-dependent formation of the direct-acting mutagen 2-nitro-3-methylimidazo[4,5-f]quinoline (nitro-IQ) from IQ.
Morrison LD; Eling TE; Josephy PD
Mutat Res; 1993 May; 302(1):45-52. PubMed ID: 7683106
[TBL] [Abstract][Full Text] [Related]
38. Two monoclonal antibodies recognizing different epitopes on rat cytochrome IIB1 react with human IIE1.
Wrighton SA; Vandenbranden M; Becker GW; Black SD; Thomas PE
Mol Pharmacol; 1992 Jan; 41(1):76-82. PubMed ID: 1370708
[TBL] [Abstract][Full Text] [Related]
39. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1.
Shimada T; Hayes CL; Yamazaki H; Amin S; Hecht SS; Guengerich FP; Sutter TR
Cancer Res; 1996 Jul; 56(13):2979-84. PubMed ID: 8674051
[TBL] [Abstract][Full Text] [Related]
40. The in vitro effects of lipid peroxidation on the content of individual forms of cytochrome P-450 in liver microsomes of guinea-pigs.
Mori T; Kitada M; Imaoka S; Funae Y; Kamataki T
Pharmacol Res; 1991 Aug; 24(2):143-8. PubMed ID: 1749745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]